Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.

Skineez® Launches First-Ever Reversible Medical Grade Compression Sock-Made in the USA Clinically Proven, Skincare-Infused, ...

Healthcare distributor and services company Cardinal Health (NYSE:CAH) will be announcing earnings results this Tuesday ...

Key Insights Institutions' substantial holdings in Cardinal Health implies that they have significant influence ...

Analysts expect the health care company to report quarterly earnings at $2.03 per share, up from $1.84 per share in the ...

Cardinal Health, Inc. (NYSE:CAH) will release earnings results for the fourth quarter before the opening bell on Tuesday, Aug ...

Approximately six in 10 U.S. adults reported taking a prescription drug, and a quarter of U.S. adults take four or more.

119 JCPenney stores sold in nearly $1 billion deal. See list of locations.

Cardinal Health’s CEO says “ruthless prioritization” was needed to turn around the Fortune 500 company whose earnings plummeted $300 million just three years ago.

Detailed price information for Agilon Health Inc (AGL-N) from The Globe and Mail including charting and trades.

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Cardinal Health (CAH) is a stock that can certainly grab the attention of many ...